Here are relevant reports on : dementia-care-device-market
-
Medical Device Outsourced Manufacturing Market by Device Type (IVD (Equipment, Consumable), Diabetes, Respiratory, Cardiovascular, Personal Care, Endoscopy, Dental, Ophthalmology, Devices) Class of Device, Services, Procedure - Forecast to 2026
The global medical device outsourced manufacturing market growth is primed to transition from $29.3 billion in 2021 to $56.2 billion by 2026, showcasing a strong CAGR of 13.9%. The medical device outsourced manufacturing market is mainly driven by the overall growth of the medical devices market, mainly due to the rising disease prevalence, life expectancy, and geriatric population. Technological advancements have prompted end users to overhaul or update their manufacturing systems.
- Published: April 2021
- Price: $ 4950
- TOC Available:
-
Mental Health Screening Market by Indication (Depression, Bipolar, Schizophrenia, ADHD, Alzheimer, Dementia), Screening (Self, Interview, Observation, Biomarker), Technology (mHealth, Remote Platform, Telehealth), Age, Setting & Region - Global Forecast to 2029
The global mental health screening market, valued at US$0.8 billion in 2022, stood at US$0.9 billion in 2023 and is projected to advance at a resilient CAGR of 12.2% from 2023 to 2029, culminating in a forecasted valuation of US$1.8 billion by the end of the period. The growth of this market is driven by the rising awareness of mental health issues, growing geriatric population and subsequent increase in the prevalence of mental disorders, and technological advancements.
- Published: March 2024
- Price: $ 4950
- TOC Available:
-
European Injectable Drug Delivery Market by Type (Device, Formulation), Therapeutic (Hormonal, Oncology), Usage Pattern (Curative Care, Immunization), Administration (Skin, Musculoskeletal), End User (Hospital, Home care Setting) - Forecast to 2020
The European injectable drug delivery market is expected to reach $207.3 Billion by 2020 from $114.7 Billion in 2015, growing at a CAGR of 12.6% from 2015 to 2020. Factors such as rising prevalence of chronic diseases, growth of the biologics market, demand of self-injection devices, and technological advancements are driving the growth of this market. On the other hand, alternative delivery methods such as oral and transdermal, safety concerns, and blood-borne infections are hindering the growth of this market.
- Published: July 2015
- Price: $ 4950
- TOC Available:
-
Injectable Drug Delivery Market by Type (Device, Formulation), Therapeutic (Infectious Diseases, Cancer, Obesity), Usage Pattern (Immunization), Administration (Skin, Musculoskeletal), End Users (Hospital, Home Care) & Region - Global Forecast to 2030
The global injectable drug delivery market, valued at US$633.77 billion in 2024, stood at US$690.23 billion in 2025 and is projected to advance at a resilient CAGR of 8.4% from 2025 to 2030, culminating in a forecasted valuation of US$1,034.78 billion by the end of the period. The injectable drug delivery market is driven by the rising prevalence of chronic diseases, such as diabetes, cancer, and autoimmune disorders, alongside an increasing global demand for biologics.
- Published: May 2025
- Price: $ 8150
- TOC Available:
-
Cardiovascular Ultrasound System Market by Test Type (Transesophageal, Stress, Transthoracic, Fetal), Technology (2D, 3D & 4D, Doppler Imaging), Device Display (Black & White, Color), End User (Hospitals, Home Care, Ambulatory)- Global Forecast to 2022
The global cardiovascular ultrasound system market size is projected to grow at a CAGR of 5.4%. The market is segmented on the basis of test type, technology, device display, end user, and region. Based on test type, the market is categorized into transthoracic echocardiogram, transesophageal echocardiogram, stress echocardiogram, and other echocardiograms. The other echocardiograms include fetal & intracardiac echocardiograms.
- Published: December 2016
- Price: $ 4950
- TOC Available:
-
IV Equipment Market by Product (Infusion Pump, Catheter, Solution and Blood Administration Set, Securement Device, Cannula, Stopcock, Needleless Connector), End User (Hospitals & Clinics, Homecare, Ambulatory Care Center) - Global Forecast to 2022
The global IV equipment market is expected to reach USD 13.63 Billion by 2022 from USD 10.07 Billion in 2017, at a CAGR of 6.2% from 2017 to 2022. The major factors driving the growth of this market include increasing incidence of chronic diseases, rapid growth in the aging population, and growing number of surgical procedures. The high growth in developing countries across Asia-Pacific and Latin America are expected to provide significant growth opportunities for players operating in the IV equipment market in the coming years.
- Published: May 2017
- Price: $ 4950
- TOC Available:
-
Medical Engineered Materials Market by Type (Medical plastics, medical foams, medical films, medical elastomers, medical adhesives), Application (Medical device, disposables, medical wearables, advanced wound care), and Region - Global Forecast to 2025
The Medical Engineered Materials Market is expected to grow from USD 15.8 billion in 2020 to USD 29.1 billion by 2025, at a CAGR of 13.0% during the forecast period. The key players in the medical engineered materials market include Evonik (Germany), Covestro (Germany), BASF (Germany), Solvay (Belgium), SABIC (Saudi Arabia), Trelleborg AB (Sweden), DSM (Netherlands), Celanese (US), and DuPont (US). These players have established a strong foothold in the market by adopting strategies, such as investment & expansion, merger & acquisition, agreement & collaboration, partnership, new product launch.
- Published: April 2021
- Price: $ 4950
- TOC Available:
-
Drug Device Combination Products Market by Type (Injectable, Transdermal Patch, Infusion Pump, Drug-eluting Stent, Inhaler), Application (Diabetes, Oncology, Pain, Opthamology), End User (Hospital, Home Care), and Region - Global Forecast to 2030
The global drug device combination products market, valued at US$224.70 billion in 2024, stood at US$243.02 billion in 2025 and is projected to advance at a resilient CAGR of 9.3% from 2025 to 2030, culminating in a forecasted valuation of US$379.17 billion by the end of the period. The increasing prevalence of chronic diseases worldwide, coupled with the introduction and approval of innovative advanced therapeutics, is driving significant market expansion.
- Published: May 2025
- Price: $ 4950
- TOC Available:
-
US Injectable Drug Delivery Market by Type (Device, Formulation), Therapeutic (Infectious Diseases, Cancer, Obesity), Usage Pattern (Immunization), Administration (Skin, Musculoskeletal), End Users (Hospital, Home Care) - Forecast to 2031
The US injectable drug delivery market, valued at US$285.81 billion in 2025, stood at US$309.90 billion in 2026 and is projected to advance at a resilient CAGR of 8.5% from 2026 to 2031, culminating in a forecasted valuation of US$465.15 billion by the end of the period. The growth of the veterinary contract manufacturing & research market is driven by the increasing adoption of biologics and long-acting injectables, rising demand for patient-centric and self-administration delivery systems, and the need for advanced formulation, device engineering, and scalable manufacturing capabilities.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Augmented and Virtual Reality in Healthcare Market by Offering (Hardware and Software), Device Type, End User, Application (Patient Care Management, Medical Training & Education, Pharmacy Management, Surgery), and Geography - Global Forecast to 2023
The augmented and virtual reality in healthcare market was valued at USD 769.2 Million in 2017 and is expected to reach USD 4,997.9 Million by 2023, at a CAGR of 36.6% during the forecast period. Some major companies operating in the market for augmented reality in healthcare and virtual reality in healthcare are Google (US), Microsoft (US), DAQRI (US), Psious (Spain), Mindmaze (Switzerland), Firsthand Technology (US), Medical Realities (UK), Atheer (US), Augmedix (US), and Oculus VR (US). The other major players in the market include CAE Healthcare (US), Philips Healthcare (Netherlands & US), 3D Systems (US), VirtaMed (Switzerland), HTC (Taiwan), Siemens Healthineers (Germany), and Virtually Better (US).
- Published: November 2017
- Price: $ 4950
- TOC Available:
Records 1 to 10 of 50
